Samantha G Bromfield1, John N Booth2, Matthew S Loop3, Joseph E Schwartz4,5, Samantha R Seals6, Stephen J Thomas7, Yuan-I Min8, Gbenga Ogedegbe9, Daichi Shimbo4, Paul Muntner2. 1. Department of Epidemiology, Emory University, Atlanta, Georgia. 2. Department of Epidemiology. 3. Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 4. Department of Medicine, Columbia University Medical Center. 5. Department of Psychiatry and Behavioral Sciences, Stony Brook University, Stony Brook, New York. 6. Department of Mathematics and Statistics, University of West Florida, Pensacola, Florida. 7. Department of Psychiatry, University of Alabama at Birmingham, Birmingham, Alabama. 8. Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA. 9. Department of Population Health, New York University Langone Medical Center, New York.
Abstract
OBJECTIVE: We determined differences in the prevalence of blood pressure (BP) phenotypes and the association of these phenotypes with left ventricular hypertrophy (LVH) for individuals who fulfilled and did not fulfill various criteria used for defining a complete ambulatory blood pressure monitoring (ABPM) recording. METHODS: We analyzed data for 1141 participants from the Jackson Heart Study. Criteria evaluated included having greater than or equal to 80% of planned readings with more than or equal to one reading per hour (Spanish ABPM Registry criteria), more than or equal to 70% of planned readings with a minimum of 20 daytime and seven nighttime readings (2013 European Society of Hypertension criteria), greater than or equal to 14 daytime and greater than or equal to seven nighttime readings (2003 European Society of Hypertension criteria), more than or equal to 10 daytime and more than or equal to 5 nighttime readings (International Database of Ambulatory Blood Pressure in Relation to Cardiovascular Outcome criteria), and greater than or equal to 14 daytime readings (UK National Institute of Health and Clinical Excellence criteria). RESULTS: Between 45.0% (Spanish ABPM Registry) and 91.8% (UK National Institute of Health and Clinical Excellence) of the participants fulfilled the different criteria for a complete ABPM recording. Across the various criteria evaluated, 55.5-57.8% of participants had nocturnal hypertension and 62.8-66.8% had nondipping systolic BP. Among participants with clinic-measured systolic/diastolic BP of more than or equal to 140/90 mmHg, 22.9-26.5% had white-coat hypertension. The prevalence of daytime, 24-h, sustained, and masked hypertension differed by up to 2% for participants fulfilling each criterion. The association of BP phenotypes with LVH was similar for participants who fulfilled versus those who did not fulfill different criteria (each P>0.05). CONCLUSION: Irrespective of the criteria used for defining a complete ABPM recording, the prevalence of BP phenotypes and their association with LVH were similar.
OBJECTIVE: We determined differences in the prevalence of blood pressure (BP) phenotypes and the association of these phenotypes with left ventricular hypertrophy (LVH) for individuals who fulfilled and did not fulfill various criteria used for defining a complete ambulatory blood pressure monitoring (ABPM) recording. METHODS: We analyzed data for 1141 participants from the Jackson Heart Study. Criteria evaluated included having greater than or equal to 80% of planned readings with more than or equal to one reading per hour (Spanish ABPM Registry criteria), more than or equal to 70% of planned readings with a minimum of 20 daytime and seven nighttime readings (2013 European Society of Hypertension criteria), greater than or equal to 14 daytime and greater than or equal to seven nighttime readings (2003 European Society of Hypertension criteria), more than or equal to 10 daytime and more than or equal to 5 nighttime readings (International Database of Ambulatory Blood Pressure in Relation to Cardiovascular Outcome criteria), and greater than or equal to 14 daytime readings (UK National Institute of Health and Clinical Excellence criteria). RESULTS: Between 45.0% (Spanish ABPM Registry) and 91.8% (UK National Institute of Health and Clinical Excellence) of the participants fulfilled the different criteria for a complete ABPM recording. Across the various criteria evaluated, 55.5-57.8% of participants had nocturnal hypertension and 62.8-66.8% had nondipping systolic BP. Among participants with clinic-measured systolic/diastolic BP of more than or equal to 140/90 mmHg, 22.9-26.5% had white-coat hypertension. The prevalence of daytime, 24-h, sustained, and masked hypertension differed by up to 2% for participants fulfilling each criterion. The association of BP phenotypes with LVH was similar for participants who fulfilled versus those who did not fulfill different criteria (each P>0.05). CONCLUSION: Irrespective of the criteria used for defining a complete ABPM recording, the prevalence of BP phenotypes and their association with LVH were similar.
Authors: Myra A Carpenter; Richard Crow; Michael Steffes; William Rock; Jeffrey Heilbraun; Gregory Evans; Thomas Skelton; Robert Jensen; Daniel Sarpong Journal: Am J Med Sci Date: 2004-09 Impact factor: 2.378
Authors: Eoin O'Brien; Gianfranco Parati; George Stergiou; Roland Asmar; Laurie Beilin; Grzegorz Bilo; Denis Clement; Alejandro de la Sierra; Peter de Leeuw; Eamon Dolan; Robert Fagard; John Graves; Geoffrey A Head; Yutaka Imai; Kazuomi Kario; Empar Lurbe; Jean-Michel Mallion; Giuseppe Mancia; Thomas Mengden; Martin Myers; Gbenga Ogedegbe; Takayoshi Ohkubo; Stefano Omboni; Paolo Palatini; Josep Redon; Luis M Ruilope; Andrew Shennan; Jan A Staessen; Gert vanMontfrans; Paolo Verdecchia; Bernard Waeber; Jiguang Wang; Alberto Zanchetti; Yuqing Zhang Journal: J Hypertens Date: 2013-09 Impact factor: 4.844
Authors: Manuel Gorostidi; Pantelis A Sarafidis; Alejandro de la Sierra; Julian Segura; Juan J de la Cruz; Jose R Banegas; Luis M Ruilope Journal: Am J Kidney Dis Date: 2013-05-18 Impact factor: 8.860
Authors: Jan Heeringa; Deirdre A M van der Kuip; Albert Hofman; Jan A Kors; Gerard van Herpen; Bruno H Ch Stricker; Theo Stijnen; Gregory Y H Lip; Jacqueline C M Witteman Journal: Eur Heart J Date: 2006-03-09 Impact factor: 29.983
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Paul Muntner; Cora E Lewis; Keith M Diaz; April P Carson; Yongin Kim; David Calhoun; Yuichiro Yano; Anthony J Viera; Daichi Shimbo Journal: Am J Hypertens Date: 2014-11-04 Impact factor: 3.080
Authors: John N Booth; Byron C Jaeger; Lei Huang; Marwah Abdalla; Mario Sims; Mark Butler; Paul Muntner; Daichi Shimbo Journal: Hypertension Date: 2020-02-03 Impact factor: 10.190
Authors: Beverly B Green; Melissa L Anderson; Andrea J Cook; Kelly Ehrlich; Yoshio N Hall; Clarissa Hsu; Dwayne Joseph; Predrag Klasnja; Karen L Margolis; Jennifer B McClure; Sean A Munson; Mathew J Thompson Journal: J Gen Intern Med Date: 2022-03-03 Impact factor: 6.473
Authors: Yuichiro Yano; Rikki M Tanner; Swati Sakhuja; Byron C Jaeger; John N Booth; Marwah Abdalla; Daniel Pugliese; Samantha R Seals; Gbenga Ogedegbe; Daniel W Jones; Paul Muntner; Daichi Shimbo Journal: JAMA Cardiol Date: 2019-09-01 Impact factor: 14.676
Authors: Beverly B Green; Melissa L Anderson; Jerry Campbell; Andrea J Cook; Kelly Ehrlich; Sarah Evers; Yoshio N Hall; Clarissa Hsu; Dwayne Joseph; Predrag Klasnja; Karen L Margolis; Jennifer B McClure; Sean A Munson; Mathew J Thompson Journal: Contemp Clin Trials Date: 2019-01-08 Impact factor: 2.226
Authors: Swati Sakhuja; John N Booth; Donald M Lloyd-Jones; Cora E Lewis; Stephen J Thomas; Joseph E Schwartz; Daichi Shimbo; James M Shikany; Mario Sims; Yuichiro Yano; Paul Muntner Journal: Am J Hypertens Date: 2019-07-17 Impact factor: 3.080
Authors: Stephen Justin Thomas; Dayna A Johnson; Na Guo; Marwah Abdalla; John N Booth; Tanya M Spruill; Chandra L Jackson; Yuichiro Yano; Mario Sims; David Calhoun; Paul Muntner; Susan Redline Journal: Am J Hypertens Date: 2020-10-21 Impact factor: 3.080
Authors: Byron C Jaeger; John N Booth; Mark Butler; Lloyd J Edwards; Cora E Lewis; Donald M Lloyd-Jones; Swati Sakhuja; Joseph E Schwartz; James M Shikany; Daichi Shimbo; Yuichiro Yano; Paul Muntner Journal: J Am Heart Assoc Date: 2020-01-09 Impact factor: 5.501
Authors: Swati Sakhuja; John N Booth; David E Anstey; Byron C Jaeger; Cora E Lewis; Donald M Lloyd-Jones; Joseph E Schwartz; Daichi Shimbo; James M Shikany; Mario Sims; Paul Muntner Journal: Am J Hypertens Date: 2020-11-03 Impact factor: 3.080
Authors: S Justin Thomas; John N Booth; Byron C Jaeger; Demetria Hubbard; Swati Sakhuja; Marwah Abdalla; Donald M Lloyd-Jones; Daniel J Buysse; Core E Lewis; James M Shikany; Joseph E Schwartz; Daichi Shimbo; David Calhoun; Paul Muntner; Mercedes R Carnethon Journal: J Am Heart Assoc Date: 2020-03-19 Impact factor: 5.501